##  [Pharma Focus Asia Features Freyr’s Insights on eCTD Evolution](/index%2ephp/freyr-in-media/pharma-focus-asia-features-freyrs-insights-on-ectd-evolution) 

Freyr Solutions' expertise on the **evolution of eCTD** is featured in **Pharma Focus Asia**, with insights from **Gouspasha Mohammed, Senior SME**. The article explores the **transition from eCTD 1.0 to 4.0**, marking a significant shift in **global regulatory submissions** through **automation, lifecycle management, and harmonization** across regulated regions like the **US, Europe, Japan, and Canada**.

eCTD 4.0 introduces **enhanced lifecycle tracking, metadata-driven validation, and interoperability with regulatory systems**, ensuring **faster approvals, efficient compliance, and reduced submission errors**. The shift from **traditional document-based processes to a standardized, structured submission format** aligns global regulatory expectations, making **digital transformation a necessity** for life sciences companies.

[Click here](https://www.pharmafocusasia.com/articles/evolution-of-ectd-from-version-1-to-4) to read the complete "Nuf Foods Spectrum" Issue.